Every 13F-reported equity position this quarter with its quarter-over-quarter change; each row traces to the filer's 13F-HR on EDGAR.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR
Every 13F-reported equity position this quarter with its quarter-over-quarter change; each row traces to the filer's 13F-HR on EDGAR.
Menlo Ventures Management, L.P. (CIK 1911541) reported $357.4M across 3 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: CHYM ($357.2M, 99.96%), BRZE ($100,078, 0.03%), SNTI ($39,311, 0.01%), SNTI ($0, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | CHYM | CHIME FINL INC | $357.2M | 99.96% | 17.4M | Hold |
| 2 | BRZE | BRAZE INC | $100,078 | 0.03% | 4,614 | Trimmed |
| 3 | SNTI | SENTI BIOSCIENCES HOLDINGS I | $39,311 | 0.01% | 35,737 | New |
| 4 | SNTI | SENTI BIOSCIENCES INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-06-30